Literature DB >> 20349269

Heart failure increases atrogin-1 and MuRF1 gene expression in skeletal muscle with fiber type-specific atrophy.

Robson Francisco Carvalho1, Eduardo Paulino Castan, Cesar Augusto Coelho, Francis Silva Lopes, Fernanda Losi Alves Almeida, Aline Michelin, Rodrigo Wagner Alves de Souza, João Pessoa Araújo, Antonio Carlos Cicogna, Maeli Dal Pai-Silva.   

Abstract

Heart failure (HF) is characterized by a reduced tolerance to exercise due to early fatigue and dyspnea; this may be due in part to skeletal muscle myopathy with a shift from slow to fast fibers and loss of muscle mass. Muscle wasting does not occur similarly in all types of muscle fiber, thus we tested the hypothesis that HF induces skeletal muscle atrophy in a fiber type-specific manner altering the expression of atrogin-1 and MuRF1 in a fast muscle of rats with monocrotaline-induced heart failure. We studied extensor digitorum longus (EDL) muscle from both HF and control Wistar rats. Atrogin-1 and MuRF1 mRNA content were determined using Real-Time RT-qPCR while muscle fiber cross-sectional area (CSA) from sections stained histochemically for myofibrillar ATPase were used as an index of type-specific fiber atrophy. The measurement of gene expression by RT-qPCR revealed that EDL muscle mRNA expression of MuRF1 and atrogin-1 was significantly increased in the HF group. Muscle fiber type IIB CSA decreased in the HF group compared to the CT group; there was no significant difference in muscle fiber types I and IIA/D CSA between the HF and CT groups. In conclusion, we showed that HF induces fiber type IIB specific atrophy, up-regulating atrogin-1 and MuRF1 mRNA expression in EDL muscle of monocrotaline treated rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349269     DOI: 10.1007/s10735-010-9262-x

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  41 in total

1.  Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle.

Authors:  Stephan Clavel; Anne-Sophie Coldefy; Emilie Kurkdjian; Jérôme Salles; Irène Margaritis; Benoît Derijard
Journal:  Mech Ageing Dev       Date:  2006-09-01       Impact factor: 5.432

Review 2.  Increased transcription of ubiquitin-proteasome system components: molecular responses associated with muscle atrophy.

Authors:  S R Price
Journal:  Int J Biochem Cell Biol       Date:  2003-05       Impact factor: 5.085

3.  Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle.

Authors:  Curtis J Wray; Joshua M V Mammen; Dan D Hershko; Per-Olof Hasselgren
Journal:  Int J Biochem Cell Biol       Date:  2003-05       Impact factor: 5.085

4.  Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions.

Authors:  Mirjam E van Albada; Beatrijs Bartelds; Hans Wijnberg; Saffloer Mohaupt; Michael G Dickinson; Regien G Schoemaker; Krista Kooi; Frans Gerbens; Rolf M F Berger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-18       Impact factor: 5.464

5.  Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.

Authors:  Esther Latres; Ami R Amini; Ashley A Amini; Jennifer Griffiths; Francis J Martin; Yi Wei; Hsin Chieh Lin; George D Yancopoulos; David J Glass
Journal:  J Biol Chem       Date:  2004-11-17       Impact factor: 5.157

6.  Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-alpha and sphingosine.

Authors:  L Dalla Libera; R Sabbadini; C Renken; B Ravara; M Sandri; R Betto; A Angelini; G Vescovo
Journal:  J Mol Cell Cardiol       Date:  2001-10       Impact factor: 5.000

7.  Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.

Authors:  Noriyuki Kimura; Toshihide Kumamoto; Takahiro Oniki; Miwa Nomura; Kenichiro Nakamura; Yoshitake Abe; Yusuke Hazama; Hidetsugu Ueyama
Journal:  Muscle Nerve       Date:  2009-04       Impact factor: 3.217

8.  Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart.

Authors:  Peter Razeghi; Kedryn K Baskin; Saumya Sharma; Martin E Young; Stanislaw Stepkowski; M Faadiel Essop; Heinrich Taegtmeyer
Journal:  Biochem Biophys Res Commun       Date:  2006-02-08       Impact factor: 3.575

9.  Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy.

Authors:  G Vescovo; C Ceconi; P Bernocchi; R Ferrari; U Carraro; G B Ambrosio; L D Libera
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

10.  Abnormalities of skeletal muscle in patients with chronic heart failure.

Authors:  D P Lipkin; D A Jones; J M Round; P A Poole-Wilson
Journal:  Int J Cardiol       Date:  1988-02       Impact factor: 4.164

View more
  19 in total

1.  Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.

Authors:  Michael L Paffett; Selita N Lucas; Matthew J Campen
Journal:  Vascul Pharmacol       Date:  2011-11-25       Impact factor: 5.773

Review 2.  Pharmacology of manipulating lean body mass.

Authors:  Patricio V Sepulveda; Ernest D Bush; Keith Baar
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-01       Impact factor: 2.557

3.  Regional skeletal muscle remodeling and mitochondrial dysfunction in right ventricular heart failure.

Authors:  Rob C I Wüst; David S Myers; Rachel Stones; David Benoist; Philip A Robinson; John P Boyle; Chris Peers; Ed White; Harry B Rossiter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

4.  Morphological aspects of neuromuscular junctions and gene expression of nicotinic acetylcholine receptors (nAChRs) in skeletal muscle of rats with heart failure.

Authors:  Paula Aiello Tomé de Souza; Selma Maria Michelin Matheus; Eduardo Paulino Castan; Dijon Henrique Salomé Campos; Antônio Carlos Cicogna; Robson Francisco Carvalho; Maeli Dal-Pai-Silva
Journal:  J Mol Histol       Date:  2011-09-18       Impact factor: 2.611

5.  Curcumin improves exercise performance of mice with coronary artery ligation-induced HFrEF: Nrf2 and antioxidant mechanisms in skeletal muscle.

Authors:  Ahmed M Wafi; Juan Hong; Tara L Rudebush; Li Yu; Bryan Hackfort; Hanjun Wang; Harold D Schultz; Irving H Zucker; Lie Gao
Journal:  J Appl Physiol (1985)       Date:  2018-11-21

6.  Differential morphofunctional characteristics and gene expression in fast and slow muscle of rats with monocrotaline-induced heart failure.

Authors:  Raquel Santilone Bertaglia; Joyce Reissler; Francis Silva Lopes; Walter Luiz Garrido Cavalcante; Fernanda Regina Carani; Carlos Roberto Padovani; Sergio Augusto Rodrigues; Antônio Carlos Cigogna; Robson Francisco Carvalho; Ana Angélica Henrique Fernandes; Marcia Gallacci; Maeli Dal Pai Silva
Journal:  J Mol Histol       Date:  2011-04-21       Impact factor: 2.611

Review 7.  Muscle training in patients with pulmonary hypertension. a narrative review.

Authors:  Vicente Benavides-Cordoba; Martijn A Spruit
Journal:  Colomb Med (Cali)       Date:  2021-12-30

Review 8.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

9.  Preventive aerobic training exerts a cardioprotective effect on rats treated with monocrotaline.

Authors:  Francis Lopes Pacagnelli; Ana Karênina Dias de Almeida Sabela; Katashi Okoshi; Thaoan Bruno Mariano; Dijon Henrique Salomé Campos; Robson Francisco Carvalho; Antônio Carlos Cicogna; Luiz Carlo Marques Vanderlei
Journal:  Int J Exp Pathol       Date:  2016-07-01       Impact factor: 1.925

10.  MST1, a key player, in enhancing fast skeletal muscle atrophy.

Authors:  Bin Wei; Wen Dui; Dong Liu; Yan Xing; Zengqiang Yuan; Guangju Ji
Journal:  BMC Biol       Date:  2013-02-01       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.